These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 21844143

  • 1. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
    Yan Z, Young AL, Hua H, Xu Y.
    J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D.
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [Abstract] [Full Text] [Related]

  • 4. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 5. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E.
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 7. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 8. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N.
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
    Bremenkamp RM, Caris AR, Jorge AO, Back-Brito GN, Mota AJ, Balducci I, Brighenti FL, Koga-Ito CY.
    Arch Oral Biol; 2011 Jun; 56(6):549-55. PubMed ID: 21183157
    [Abstract] [Full Text] [Related]

  • 10. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
    Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P.
    Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
    [Abstract] [Full Text] [Related]

  • 11. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R.
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [Abstract] [Full Text] [Related]

  • 12. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group.
    J Infect Dis; 2001 Jan 15; 183(2):286-93. PubMed ID: 11204125
    [Abstract] [Full Text] [Related]

  • 13. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul 15; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 14. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magaró HM.
    Mycoses; 2009 Jan 15; 52(1):53-9. PubMed ID: 18498298
    [Abstract] [Full Text] [Related]

  • 15. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Jan 15; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
    Dorocka-Bobkowska B, Konopka K.
    Int J Prosthodont; 2007 Jan 15; 20(5):504-6. PubMed ID: 17944341
    [Abstract] [Full Text] [Related]

  • 17. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR.
    Indian J Pathol Microbiol; 2009 Jan 15; 52(4):501-4. PubMed ID: 19805956
    [Abstract] [Full Text] [Related]

  • 18. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
    Fernández Andreu CM, Martínez Machin G, Illnait Zaragozi MT, Perurena Lancha MR, Aguila Sánchez A, Galloso Brito M.
    Rev Cubana Med Trop; 2007 Jan 15; 59(2):113-8. PubMed ID: 23427444
    [Abstract] [Full Text] [Related]

  • 19. Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care.
    Leung KC, McMillan AS, Cheung BP, Leung WK.
    Oral Dis; 2008 Mar 15; 14(2):163-73. PubMed ID: 18302677
    [Abstract] [Full Text] [Related]

  • 20. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M, Sadeghi G, Zeinali E, Alirezaee M, Shams-Ghahfarokhi M, Amani A, Mirahmadi R, Tolouei R.
    J Mycol Med; 2014 Jun 15; 24(2):e43-50. PubMed ID: 24767256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.